ten patients on chronic intermittent hemodialysis treatment received either unfractionated heparin or low molecular weight ( lmw ) heparin k 2165 in a single-blinded randomized cross-over study to assess : effects on hemostasis and ex vivo platelet functions , and effectiveness , i.e . prevention of fibrin formation in the extracorporeal circuit .
C0019134
unfractionated heparin
C0019139
low molecular weight